Sanjeev Kumar Sethi

Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.

Ranbaxy Laboratories Ltd. operated as an integrated international pharmaceutical organization. The company engaged in the marketing, production and distribution of pharmaceutical products. It manufactured and markets molecules and their combinations to therapies, which include anti-infective, cardiovascular, pain management, central nervous system, gastrointestinal, respiratory, dermatology, orthopedics, nutritionals and urology. The company was founded on June 16, 1961 and headquartered in Gurgaon, India.

Mylan Laboratories Ltd. manufactures and supplies active pharmaceutical ingredients. The firm operates through two segments: Pharmaceuticals and Medical Supplies. It manufactures and supplies generic and branded generic formulations to various markets, including North America, Europe and Asia Pacific. Mylan Laboratories was founded on November 29, 1984 and is headquartered in Hyderabad, India.

Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.

Part of Viatris, Inc., Mylan Pharmaceuticals Pvt Ltd. is an Indian pharmaceutical company. The private company is based in Bangalore, India. Mylan Pharmaceuticals values its workforce of about 15,000 people and encourages them to connect, collaborate, and communicate.

Part of Viatris, Inc., Famy Life Sciences Pvt Ltd. is a pharmaceutical company based in Ahmedabad, India. Founded in 2008, Famy Life Sciences was acquired by Viatris, Inc. on January 03, 2023 for $3.41 million.